ICER weighing issuing advice on trial design

The Institute for Clinical and Economic Review is evaluating whether to collaborate earlier than it now does with drug companies by offering advice on clinical trial designs.

ICER spokesperson David Whitrap said the institute is considering launching an early scientific advice program to guide clinical trial design in an effort to more adequately measure "outcomes that matter most to patients and their families."...